Hinshaw William 4
4 · Axcella Health Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Hinshaw William
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-01-28+50,000→ 50,000 total - Sale
Common Stock
2022-01-31$1.65/sh−16,590$27,393→ 33,410 total - Exercise/Conversion
Restricted Stock Units
2022-01-28−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
- [F2]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]The restricted stock units vested in full on January 28, 2022.